Scilex Holding SCLX
NASDAQ SCLX
$4.41 -0.04 (-0.90%)
As of: Oct 1, 2026 · 3:59 PM EDT

Scilex Holding (SCLX) Non Operating Interest Expenses (2021 - 2026)

Updated

Scilex Holding's Non Operating Interest Expenses was $6.1 million in Q2 2026, up 127.6% from $2.68 million a year earlier and up 61.5% from the prior quarter.

Analysis

Scilex Holding (SCLX) Non Operating Interest Expenses (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Scilex Holding's Non Operating Interest Expenses was $16.18 million through Jun 30, 2026, up 168.6% year-over-year; for FY2025, it was $11.46 million, up 483.7% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of -2.7% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $1.96 million in FY2024 (+83.8%), $1.07 million in FY2023 (-88.9%), $9.6 million in FY2022 (-18.4%) and $11.76 million in FY2021 (-10.3%).
  • The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses in data going back to Q4 2021.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in six of the last seven quarters, with growth averaging 180.9%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q3 2025 (growth of 385.8%); the worst was Q3 2023 (a decline of 72.4%).
  • Per Business Quant data, SCLX's Non Operating Interest Expenses in the three quarters before Q2 2026 was $3.78 million (Q1 2026), $3.5 million (Q4 2025) and $2.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Scilex Holding 31.30 Mn 19.28 Mn 3.97 Mn 6.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.10 Mn
Mar 31, 2026 3.78 Mn
Dec 31, 2025 3.50 Mn
Sep 30, 2025 2.80 Mn
Jun 30, 2025 2.68 Mn
Mar 31, 2025 2.48 Mn
Dec 31, 2024 285,000.00
Sep 30, 2024 576,000.00
Jun 30, 2024 571,000.00
Mar 31, 2024 531,000.00
Dec 31, 2023 551,000.00
Sep 30, 2023 513,000.00
Jun 30, 2023 5,000.00
Mar 31, 2023 -1,000.00
Dec 31, 2022 1.01 Mn
Sep 30, 2022 1.86 Mn
Jun 30, 2022 8,280.00
Mar 31, 2022 7,466.00
Dec 31, 2021 50,000.00
API Access

Scilex Holding Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SCLX&period=max&api_key=YOUR_API_KEY